• S20:E1 – Clinical Implications of Trophoblast-Cell Surface Antigen 2 (TROP2) in Non-Small Cell Lung Cancer (NSCLC)

  • Jan 29 2024
  • Length: 26 mins
  • Podcast

S20:E1 – Clinical Implications of Trophoblast-Cell Surface Antigen 2 (TROP2) in Non-Small Cell Lung Cancer (NSCLC)

Listen for free

View show details

  • Summary

  • In this episode, Clinical Implications of Trophoblast-Cell Surface Antigen 2 in Non-Small Cell Lung Cancer, Dr. Justin Gainor and Dr. Helena Yu discusses the current diagnosis and treatment of non-small cell lung cancer as well as a new ADC target, trophoblast cell-surface antigen 2 or Trop2.

    Visit https://suiteweb.atpointofcare.com/#library/nsclc/2606.11/page/0 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.
    Show more Show less
Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about S20:E1 – Clinical Implications of Trophoblast-Cell Surface Antigen 2 (TROP2) in Non-Small Cell Lung Cancer (NSCLC)

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available